RxDoctor Payments Data

Duren Ready, MD

Family Medicine · Temple, TXNPI 1073581278

Payments from drug & device makers

$211,226in general payments, 2019–2025

Across 372 payments — averaging $567.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$81K
  • AbbVie$31K
  • Teva Pharmaceuticals USA, Inc.$27K
  • Amgen$25K
  • Biohaven Pharmaceuticals, Inc.$20K
  • Lundbeck LLC$17K
  • plus $10K from 9 others

What the payments were for

  • Consulting fees$29,68014%
  • Speaking & faculty fees$161,24576%
  • Grants$440%
  • Travel & lodging$11,2945%
  • Food & beverage$8,8014%
  • Education$1610%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$211,226 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$36,019
Medicare patients
125
Services billed
417

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Emgality PenGalcanezumab-Gnlm34$27,490
Candesartan Cilexetil61$5,204
Tizanidine Hcl259$4,505
Zonisamide116$2,927
Sumatriptan31$2,924
Eletriptan HbrEletriptan Hydrobromide52$2,879
RizatriptanRizatriptan Benzoate98$2,536
Topiramate102$2,242
Memantine Hcl75$1,704
Naratriptan Hcl86$1,634
Sumatriptan Succinate96$1,186
Buprenorphine Hcl18$845
Gabapentin34$803
Divalproex Sodium15$598
Amitriptyline Hcl36$559

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCOlanzapine$81,273$8149 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Temple

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →